SCHEMBL29944709

SCHEMBL29944709

CN(C(=O)OCc1ccccc1)[C@@H](CO[Si](C)(C)C(C)(C)C)c1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.39
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
BTN3A1 O00481 1/20 0.36
UTS2R Q9UKP6 2/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.36
OPRK1 P41145 3/20 0.35
PPARA Q07869 3/20 0.35
PPARG P37231 1/20 0.35
PRKCA P17252 1/20 0.35
PRKCD Q05655 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29944667 1.00 ABCB1 (0.39) ABCB1TP53POLBRXFP1BTN3A1
SCHEMBL21979527 0.83 LMNA (0.35) POLBUTS2RMEN1LMNAKMT2A
SCHEMBL21979525 0.83 LMNA (0.35) POLBUTS2RMEN1LMNAKMT2A
SCHEMBL21979522 0.83 LMNA (0.35) POLBUTS2RMEN1LMNAKMT2A
SCHEMBL29944719 0.81 ABCB1 (0.46) ABCB1TP53POLBRXFP1UTS2R
SCHEMBL29944688 0.81 ABCB1 (0.46) ABCB1TP53POLBRXFP1UTS2R
SCHEMBL17352069 0.80 ITGB3 (0.44) ABCB1BTN3A1
SCHEMBL29944721 0.78 TP53 (0.50) TP53MEN1LMNAKMT2AOPRK1
SCHEMBL29944699 0.78 TP53 (0.50) TP53MEN1LMNAKMT2AOPRK1
SCHEMBL28441147 0.75 ABCB1 (0.39) ABCB1BTN3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479533-B2 Inhibitors of Rho associated coiled-coil containing protein kinase KADMON CORPORATION, LLC (US) 2022-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11479533-B2 Inhibitors of Rho associated coiled-coil containing protein kinase ROCK1, ROCK2, RHOT2 ABCB1 4058/4885TP53 2687/4885POLB 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.